Brought to you by 
NovoCure secures Big Pharma funding in early round
12 Oct 2015
Executive Summary
Standen Ltd., which does business as NovoCure (electric energy device to treat cancer), has completed an early-stage round with participation by new investors Index Ventures, Johnson & Johnson Development Corp., and Pfizer Inc., joined by returning backer WFD Ventures.
Deal Industry
- Medical Devices
-
Medical Devices
- Radiofrequency Devices
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
NovoCure secures Big Pharma funding in early round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice